surmount-4 tirzepatide withdrawal weight regain for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Rebound Weight Gain After Stopping
Description
Niacinamide supports NAD+ production and may improve insulin sensitivity further

The medication neither increased nor decreased UTI risk in any meaningful way

What to ask your provider at each dose review Is my current weight loss progress on track for my goals

Split dosing maintains the same total weekly drug exposure
